FDA Inspection
Musculoskeletal Transplant Foundation - TSABMusculoskeletal Transplant Foundation - TSAB – FDA Inspection, Oct 26, 2010
Record Details
This FDA Inspection record concerns Musculoskeletal Transplant Foundation - TSAB, with an inspection on October 26, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 26, 2010
- Product Type
- Biologics
View Company Profile
ID · 62c8f1ff-e408-4873-9b2a-ea675e62af44
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 695079
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Musculoskeletal Transplant Foundation - TSAB
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 9, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 7, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 14, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Musculoskeletal Transplant Foundation - TSAB
- FDA Inspection 1017172 - 2017-06-16
- FDA Inspection 921627 - 2015-04-09
- FDA Inspection 813104 - 2013-01-07
- FDA Inspection 557665 - 2009-01-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.